ADA2 NOW Trademark

Trademark Overview

On Thursday, April 18, 2024, a trademark application was filed for ADA2 NOW with the United States Patent and Trademark Office. The USPTO has given the ADA2 NOW trademark a serial number of 98506745. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, February 4, 2025. This trademark is owned by DADA2 Foundation. The ADA2 NOW trademark is filed in the Medical Instrument Products category with the following description:

Point-of-care medical diagnostic device for the quantitative determination and monitoring of adenosine deaminase 2
ada2 now

General Information

Serial Number98506745
Word MarkADA2 NOW
Filing DateThursday, April 18, 2024
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, February 4, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 10, 2024

Trademark Statements

Pseudo MarkADA TWO NOW
NOT AVAILABLE"ADA2"
Goods and ServicesPoint-of-care medical diagnostic device for the quantitative determination and monitoring of adenosine deaminase 2

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateWednesday, November 6, 2024
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameDADA2 Foundation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressFranklin, TN 37069
Party NameDADA2 Foundation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressFranklin, TN 37069

Trademark Events

Event DateEvent Description
Thursday, April 18, 2024NEW APPLICATION ENTERED
Thursday, May 2, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, May 2, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, October 3, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 1, 2024NON-FINAL ACTION E-MAILED
Thursday, May 2, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, October 31, 2024ASSIGNED TO EXAMINER
Friday, November 1, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, November 1, 2024NON-FINAL ACTION WRITTEN
Wednesday, November 6, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 6, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 6, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, November 8, 2024FINAL REFUSAL WRITTEN
Friday, November 8, 2024FINAL REFUSAL E-MAILED
Friday, November 8, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, November 11, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, November 11, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, November 11, 2024TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, November 13, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 4, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 10, 2024PUBLISHED FOR OPPOSITION
Tuesday, December 10, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 4, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Related Keywords

determination monitoring adenosine deaminase quantitative device care medical diagnostic point